{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-124543","form_type":"8-K","ticker":"AGEN","cik":"0001098972","company_name":"AGENUS INC","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.663521+00:00","generated_at":"2026-05-30T01:33:21.802863+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Agenus Q3 2024 net loss $67.2M, cash $44.8M; BOT/BAL shows MSS CRC promise","bullets":["Cash $44.8M at Sept 30, 2024 (vs $76.1M Dec 2023); raised $7.1M via ATM post-quarter.","Q3 2024 revenue $25.1M (non-cash); net loss $67.2M; cash used in ops 9M 2024 $129.7M (down from $183.8M YoY).","BOT/BAL combination shows unprecedented outcomes in neoadjuvant MSS CRC (ESMO GI 2024) and advanced sarcomas (ESMO 2024).","Strategic initiatives: real estate monetization discussions advancing; near-term transaction expected to deliver substantial resources.","EMA agreement on dose selection and trial design for Phase 3 study in MSS CRC."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-124543","json":"https://secwatch.observer/filing/0000950170-24-124543.json","markdown":"https://secwatch.observer/filing/0000950170-24-124543.md","text":"https://secwatch.observer/filing/0000950170-24-124543.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1098972/000095017024124543/0000950170-24-124543-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1098972/000095017024124543/agen-20241112.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T01:33:21.802863+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}